• ATP Solution for mRNA and Kinase Workflows

  2026-09-03

  A ready-to-use ATP Solution supports reproducible in vitro transcription, kinase, ligation, and phosphorylation workflows that underpin modern mRNA–LNP research. This guide connects reagent handling and assay optimization to the localized p21 mRNA–LNP bladder cancer strategy described in the reference study.

• Berberine Hydrochloride in AMPK-Mitochondrial Studies

  2026-09-03

  Berberine hydrochloride offers a defined chemical tool for connecting AMPK activation with lipid metabolism, apoptosis, and mitochondrial stress assays. This guide translates cardiotoxicity research into a rigorous workflow for metabolic, cancer, and cardiovascular disease research.

• Cyclic Pifithrin-α: Mapping p53 in Translation

  2026-09-02

  Cyclic Pifithrin-α hydrobromide is a chemical p53 inhibitor for separating p53-dependent stress responses from broader injury biology. This thought-leadership guide connects apoptosis, DNA damage, radioprotection, and the Ca2+-CGRP/SP-Piezo2 axis while defining evidence boundaries for translational studies.

• Phosbind Acrylamide for Protein Phosphorylation Analysis

  2026-09-02

  Phosbind Acrylamide enables antibody-free separation of phosphorylated and non-phosphorylated proteins during SDS-PAGE, making it useful for kinase assays and signaling research. This practical guide connects phosphate-affinity gel design with the MAPK–SNARE13 findings reported in peach defense biology.

• SAG for Hedgehog Pathway Activation and Neuroprotection

  2026-09-01

  SAG provides a controllable Smoothened receptor agonist strategy for pathway activation, astrocyte rescue, mitochondrial assays, and developmental model design. This workflow translates evidence from frataxin-deficient astrocytes into practical dose selection, neuron–glia experiments, and troubleshooting decisions.

• CD28–ARS2 Control of CD8+ T Cell Metabolism

  2026-09-01

  Holling and colleagues identify a CD28–ARS2 signaling axis that reshapes PKM alternative splicing, favors PKM2, and gives activated CD8+ T cells greater flexibility in glucose catabolism. The study links nuclear RNA-processing control to interferon-γ production and antitumor function, while also showing that this metabolic pathway is separable from canonical CD28–PI3K signaling.

• Isochlorogenic Acid A Disrupts the HBV Life Cycle

  2026-08-31

  The reference study shows that isochlorogenic acid A (ICAA) suppresses HBV at multiple stages, including transcription, cccDNA-associated activity, capsid maturation, and particle envelopment. Its effects correlate with HO-1 upregulation and intracellular ROS remodeling, providing a mechanistic framework for studying redox control of HBV morphogenesis rather than treating viral load as a single endpoint.

• 5X Protein Loading Buffer (Reducing) Guide

  2026-08-31

  5X Protein Loading Buffer (Reducing) prepares protein samples for conventional SDS-PAGE by combining SDS-mediated denaturation with sulfhydryl reduction and tracking dye. It is intended for molecular-weight-based separation, not native-complex analysis or workflows that must preserve non-reducing disulfide patterns.

• CCG-1423: A Mechanism-First RhoA Assay Guide

  2026-08-30

  CCG-1423 is a RhoA inhibitor that interrogates MRTF-A nuclear import rather than simply measuring downstream contractility. This mechanism-first guide connects cancer research assays with the RhoA/ROCK1/MLC2 evidence from a recent MVC infection study while clarifying practical controls, readouts, and limitations.

• Tomivosertib: A Translation-Focused GBM Strategy

  2026-08-29

  Tomivosertib is a potent MNK1 inhibitor for dissecting eIF4E-dependent translation in glioblastoma models. This article develops an assay-centered framework that connects tumor-cell survival, endothelial angiogenesis, chemotherapy response, and pathway-specific interpretation.

• Toremifene Citrate: Evidence and Clinical Translation

  2026-08-28

  The reference article presents Toremifene Citrate as a nonsteroidal antiestrogen and oral selective estrogen receptor modulator for postmenopausal patients with advanced hormone receptor-positive or unknown-status breast cancer. Its main contribution is an implementation-focused synthesis linking receptor pharmacology, comparative efficacy with tamoxifen, metabolism, safety monitoring, drug interactions, and patient-management considerations.

• EZ Cap™ OVA mRNA: Designing Cleaner Immune Assays

  2026-08-28

  EZ Cap™ OVA mRNA provides a defined Cap 1-capped Ovalbumin mRNA template for interpretable immune, expression, and vaccine studies. This article presents a delivery-aware framework for separating transcript quality from formulation and inflammatory variables.

• EZ Cap™ Cas9 mRNA for Causal Neurobiology

  2026-08-27

  Explore how EZ Cap™ Cas9 mRNA (5-moUTP) can support causal gene editing studies of Fyn–Stat3 neuroinflammation. This article connects mRNA design, transient CRISPR-Cas9 genome editing, and assay architecture for more rigorous zebrafish neurobiology research.

• Streptavidin-Cy3 for Super-Enhancer RNA Imaging

  2026-08-27

  Streptavidin-Cy3 converts biotinylated probes, antibodies, and nucleic acids into bright Cy3 signals for spatial studies of super-enhancer RNA and NDRG1-linked metastasis. This practical guide connects assay design, imaging, flow cytometry, and troubleshooting to the mechanistic findings reported in nasopharyngeal carcinoma research.

• BH4 Oxidation Links H2O2 to ERK1/2 in DRG Neurons

  2026-08-26

  The reference study identifies oxidation-derived H2O2, rather than BH4 itself, as the signal that increases ERK1/2 phosphorylation in rat dorsal root ganglion neurons. Its pharmacological data place B-Raf upstream of MEK1/2 and ERK1/2, revealing a potentially selective mechanism for studying BH4-associated nociceptor sensitization without broadly reducing BH4 levels.

8429 records 1/562 page Next 12345 下5页 Last page